Strategies for Optimizing Bacillus Calmette-Guérin-Reference-Cited by-同舟云学术

Strategies for Optimizing Bacillus Calmette-Guérin

Published:2013-05 Issue:2 Volume:40 Page:211-218
ISSN:0094-0143
Container-title:Urologic Clinics of North America
language:en
Short-container-title:Urologic Clinics of North America

Author:

Shah Jay B.,Kamat Ashish M.

Publisher

Elsevier BV

Subject

Urology

Reference58 articles.

1. Early history of BCG;Guerin,1957

2. BCG vaccination against tuberculosis;Rosenthal,1957

3. Proof-of-concept, randomized, controlled clinical trial of bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes;Faustman;PLoS One,2012

4. Use of Bacille Calmette-Guèrin (BCG) in multiple sclerosis;Ristori;Neurology,1999

5. The effect of Bacille Calmette-Guérin on the evolution of new enhancing lesions to hypointense T1 lesions in relapsing remitting MS;Paolillo;J Neurol,2003

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the efficacy of BCG intravesical immunotherapy using the conventional Rotisserie method with the non-Rotisserie method;African Journal of Urology;2023-10-12

2. Tailoring the dose of Moscow strain of intravesical bacillus Calmette-Guérin for Indian patients: A plea for urgent action;Indian Journal of Urology;2022

3. Does Switching Bacillus Calmette-Guerin Strains During Maintenance Therapy Affect the Outcome in Non-Muscle Invasive Bladder Cancer?;Urology;2021-12

4. Innate immune memory is associated with increased disease-free survival in bladder cancer patients treated with bacillus Calmette-Guérin;Canadian Urological Association Journal;2021-01-04

5. Clinical interest of PD-L1 immuno-histochemistry expression as a predictive factor of Bacillus Calmette Guerin (BCG) efficacy in refractory high-risk non-muscle-invasive bladder cancer (NMIBC);World Journal of Urology;2019-09-05